C07C 233/30
Having the nitrogen atom of at least one of the carboxamide groups
Official title: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
C07C233/30 (Having the nitrogen atom of at least one of the carboxamide groups) appears on 344 US grants and 234 published applications in this corpus.
Search patents in C07C- Granted patents
- 344
- Published applications
- 234
- Assignees
- 228
- Inventors
- 927
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 3 | 0 |
| 1980 | 8 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 1 | 0 |
| 1993 | 5 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 32 | 0 |
| 1997 | 25 | 0 |
| 1998 | 20 | 0 |
| 1999 | 27 | 0 |
| 2000 | 13 | 0 |
| 2001 | 10 | 1 |
| 2002 | 16 | 13 |
| 2003 | 5 | 13 |
| 2004 | 5 | 21 |
| 2005 | 6 | 10 |
| 2006 | 8 | 8 |
| 2007 | 8 | 13 |
| 2008 | 7 | 13 |
| 2009 | 6 | 7 |
| 2010 | 5 | 5 |
| 2011 | 6 | 8 |
| 2012 | 5 | 6 |
| 2013 | 9 | 12 |
| 2014 | 5 | 8 |
| 2015 | 8 | 9 |
| 2016 | 10 | 17 |
| 2017 | 11 | 7 |
| 2018 | 8 | 5 |
| 2019 | 3 | 10 |
| 2020 | 10 | 13 |
| 2021 | 5 | 9 |
| 2022 | 12 | 9 |
| 2023 | 4 | 5 |
| 2024 | 6 | 3 |
| 2025 | 7 | 7 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles4 Aug 2026US 12,697,310 B2Montefiore Medical Center
- Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene4 Aug 2026US 12,698,255 B2ImmuneBridge Inc.
- 4-membered ring carboxamides used as nematicides6 Jan 2026US RE50,724 E1Syngenta Crop Protection AG
- Semisynthetic process for the preparation of colchicine11 Nov 2025US 12,467,070 B2Indena S. P. A.
- Sphingolipid, and dermatologic composition comprising same for external application14 Oct 2025US 12,441,678 B2Croda Korea Ltd
- Compounds and method for upregulation of p53 through induction of mdm2 degradation3 Sep 2026US 2026/0257987 A1Georgia State University Research Foundation, Inc.
- Compositions and methods for treating cancer15 Jan 2026US 2026/0015316 A1Cedars-Sinai Medical Center
- Small molecule antagonists of pf411 Sep 2025US 2025/0281424 A1Fox Chase Chemical Diversity Center, Inc.
- Sunscreen compounds and formulations17 Jul 2025US 2025/0228757 A1Oregon State University
- Aminoketone compound, and preparation method therefor and use thereof5 Jun 2025US 2025/0177324 A1Shanghai Zhigen Pharmaceutical & Technology Co., Ltd.
Most cited
By later US patents
- Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics115US 5,364,866 AHoechst-Roussel Pharmaceuticals Inc. · 1994
- Relieving hypertension with carboxyalkylacylamino acids81US 4,206,232 AE. R. Squibb & Sons, Inc. · 1980
- 2-amino-1,3-propanediol compound and immunosuppressant76US 5,604,229 ATaito Co., Ltd. · 1997
- Process for conditioning substances54US 5,709,884 AAstra Aktiebolag · 1998
- Modified lysine-mimetic compounds47US 7,622,496 B2Wyeth · 2009